Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma

Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen J.; Flaherty, Keith T.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; de Groot, Jan Willem B.; Loquai, Carmen; Gollerkeri, Ashwin; Pickard, Michael D.; Robert, Caroline

dc.contributor.author	Garbe, Claus
dc.date.accessioned	2020-10-20T08:14:05Z
dc.date.available	2020-10-20T08:14:05Z
dc.date.issued	2020
dc.identifier.issn	1879-0852
dc.identifier.uri	http://hdl.handle.net/10900/108078
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2019.11.016	de_DE
dc.subject.ddc	610	de_DE
dc.title	Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200715072417_01855
utue.publikation.seiten	33-44	de_DE
utue.personen.roh	Ascierto, Paolo A.
utue.personen.roh	Dummer, Reinhard
utue.personen.roh	Gogas, Helen J.
utue.personen.roh	Flaherty, Keith T.
utue.personen.roh	Arance, Ana
utue.personen.roh	Mandala, Mario
utue.personen.roh	Liszkay, Gabriella
utue.personen.roh	Garbe, Claus
utue.personen.roh	Schadendorf, Dirk
utue.personen.roh	Krajsova, Ivana
utue.personen.roh	Gutzmer, Ralf
utue.personen.roh	de Groot, Jan Willem B.
utue.personen.roh	Loquai, Carmen
utue.personen.roh	Gollerkeri, Ashwin
utue.personen.roh	Pickard, Michael D.
utue.personen.roh	Robert, Caroline
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Volume	126	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE